Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

• Published in: The New England journal of medicine Vol. 382; no. 17; p. e38
• Main Authors: Zhang, Yan, Xiao, Meng, Zhang, Shulan, Xia, Peng, Cao, Wei, Jiang, Wei, Chen, Huan, Ding, Xin, Zhao, Hua, Zhang, Hongmin, Wang, Chunyao, Zhao, Jing, Sun, Xuefeng, Tian, Ran, Wu, Wei, Wu, Dong, Ma, Jie, Chen, Yu, Zhang, Dong, Xie, Jing, Yan, Xiaowei, Zhou, Xiang, Liu, Zhengyin, Wang, Jinglan, Du, Bin, Qin, Yan, Gao, Peng, Qin, Xuzhen, Xu, Yingchun, Zhang, Wen, Li, Taisheng, Zhang, Fengchun, Zhao, Yongqiang, Li, Yongzhe, Zhang, Shuyang
• Format: Journal Article
• Language: English
• Published: United States Massachusetts Medical Society 23.04.2020
• Series: Covid-19 Cases
• Subjects: Aged; Antibodies, Anti-Idiotypic - blood; Antibodies, Anticardiolipin - blood; Antibodies, Antiphospholipid - blood; Antiphospholipid antibodies; Blood Coagulation Disorders - etiology; Coronavirus Infections - blood; Coronavirus Infections - complications; Coronaviruses; Correspondence; COVID-19; Glycoproteins; Humans; Immunoglobulin A - immunology; Immunoglobulin G - immunology; Immunoglobulins; Intensive care; Male; Pandemics; Patients; Pneumonia, Viral - blood; Pneumonia, Viral - complications; Severe acute respiratory syndrome coronavirus 2

The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit. Coagulopathy and antiphospholipid antibodies were seen in all three patients.